—EA
— • —
$202.74
P/E
76.01
PEG
—
FCF Yield
—
Rev Growth YoY
-56.0% YoY
Gross Margin
7826.0%
Health Score
4/10
D/E Ratio
0.29
Confidence
LOW
Business Snapshot
The ticker and exchange identifiers are absent from this data payload, which limits contextual framing. Based on available financial ratios — a Price/Sales of 6.94x, P/E of 76.01x, and a current price of $202.74 — this appears to be a publicly listed equity. Without market capitalisation data, a definitive cap-tier classification cannot be made, though the valuation multiples are consistent with a mid-to-large cap growth-oriented name.
Financial Health
Score: 4/10 The balance sheet carries a conservative Debt/Equity of 0.29x, which is a clear positive. However, the current ratio of 0.95x sits just below the 1.0x threshold, suggesting current liabilities slightly exceed current assets — a mild liquidity concern...
Risk Assessment
- **GROWTH DETERIORATION:** Revenue declined 56.0% year-over-year, indicating a dramatic and potentially structural contraction in business activity. - **EARNINGS COLLAPSE:** Earnings growth of -3,204.0% year-over-year represents a near-total destruction of profitability on a comparative basis. - **OVERVALUATION:** P/E of 76.01x is approximately 3x the sector average of 25x, with no DCF estimate to provide a credible fair-value floor. - **LIQUIDITY PRESSURE:** Current ratio of 0.95x means current liabilities exceed current assets, leaving limited short-term financial buffer. - **TECHNICAL DETERIORATION:** A confirmed death cross (50-day MA crossing below 200-day MA) with price trading below both moving averages signals sustained bearish price momentum....